Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole Prophylaxis in Children with CGD (iPOD)
NCT00799071Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of posaconazole in chronic granulomatous disease (CGD), sponsored by Radboud University Medical Center. Primary endpoint: Posaconazole trough plasma concentrations at Day 30. Started Feb 2009; status: completed.
02
Drugs
posaconazole
03
Conditions
chronic granulomatous disease (CGD)
Beyond the preview
Go deeper on NCT00799071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799071.